<DOC>
	<DOCNO>NCT01157377</DOCNO>
	<brief_summary>This study evaluate safety efficacy AGN-214868 patient idiopathic overactive bladder ( IOAB ) urinary incontinence .</brief_summary>
	<brief_title>Safety Efficacy Study AGN-214868 Patients With Idiopathic Overactive Bladder Urinary Incontinence</brief_title>
	<detailed_description />
	<mesh_term>Urinary Bladder , Overactive</mesh_term>
	<criteria>If female , must nonreproductive potential If male , must agree use acceptable contraception Symptoms overactive bladder urinary urgency incontinence Inadequate response limit side effect anticholinergic treatment OAB Overactive bladder cause neurological condition ( eg , spinal cord injury , multiple sclerosis ) History bladder surgery Treatment botulinum toxin therapy serotype nonurological condition within prior 12 week Previous treatment botulinum toxin therapy serotype urological condition</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>75 Years</maximum_age>
	<verification_date>February 2014</verification_date>
</DOC>